Ignite Creation Date:
2025-12-24 @ 12:08 PM
Ignite Modification Date:
2026-03-26 @ 3:08 PM
Study NCT ID:
NCT02398461
Status:
COMPLETED
Last Update Posted:
2018-08-22
First Post:
2015-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse
Sponsor:
Acorda Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IM22-MS-1033
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |